QNTM · Quantum Biopharma Ltd. · Financials
Market Cap
$24.75M
Shares
6.43M
Volume · Oct 5
243.83K
Avg daily vol (3M)
193.12K
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Operating Cash Flow
-$8.24M
-19.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| CAD | — | — | — | — | — | — | 257.1K |
| CAD | — | — | — | — | — | — | 1.96M |
| CAD | — | — | — | — | — | — | -2.41M |
| $2.76M | $6.08M | $3.86M | $6.91M | $6.33M | $7.83M | $0 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Borrowings | 2025-12-31 | USD 1,300,549 | 20-F filed 2026-03-26 |
| Current lease liabilities | 2025-12-31 | USD 103,165 | 20-F filed 2026-03-26 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.